Treatment decision - Jeg har Kræft

Cancer’s energy pathways, energy supply. Supply routes. Metabolic approaches to cancer treatment. Table of energy supply pathways and which medications block them. Glycolysis. Glutaminolysis. Angiogenesis. Fatty acid metabolism. Autophagy.

June 7, 2026
Signaling pathways in cancer. Table of signaling pathways and which medications block them. mTOR. Block pathways. PI3K/Akt. mTOR. NF-κB. Wnt/β-catenin. MAPK/ERK. STAT3. AMPK. Notch signaling pathway. Hedgehog signaling pathway.

June 6, 2026
Prostate cancer – Metabolic approaches to cancer treatment.

June 6, 2026
Bladder cancer and UTUC (renal pelvis/ureter) – Metabolic approaches to cancer treatment. Urothelial carcinoma. FGFR3. Cisplatin resistance.

June 6, 2026
Adrenocortical cancer – Metabolic approaches to cancer treatment for adrenocortical cancer. Adrenocortical carcinoma. ACC. Mitotane. Cushing’s syndrome. Hyperaldosteronism. IGF-2.

June 6, 2026
Kidney cancer (RCC). Urinary tract cancer. Metabolic approaches to cancer treatment for kidney cancer. Pathway blocking. Renal cell carcinoma. VHL mutation. HIF-1α. Clear cell renal cell carcinoma. Angiogenesis.

June 6, 2026
Select BRAF mutation – Metabolic approaches to cancer treatment for different types of BRAF mutation

June 6, 2026
Metaplastic cancers – Metabolic approaches to cancer treatment for different types of metaplastic cancer.

June 6, 2026
Bowel cancer. Colon cancer. Colon cancer. Adenocarcinoma. MSS. MSI-High. KRAS mutation. BRAF mutation. PIK3CA mutation. Mucinous carcinoma. Signet ring cell carcinoma. Right-sided colon cancer. Left-sided colon cancer. Metastatic colon cancer. Metabolic blocking.

June 6, 2026
Esophageal cancer – Block pathways. Metabolic approaches to cancer treatment. Cancer of the esophagus. Oesophageal cancer. Esophageal cancer.

June 6, 2026